Authors: Plunkett, TA Hanby, AM Miles, DW Rubens, RD

Citation: Ta. Plunkett et al., Metastatic eccrine porocarcinoma: Response to docetaxel (Taxotere) chemotherapy, ANN ONCOL, 12(3), 2001, pp. 411-414

Authors: Plunkett, TA Smith, P Rubens, RD

Citation: Ta. Plunkett et al., Risk of complications from bone metastases in breast cancer: implications for management, EUR J CANC, 36(4), 2000, pp. 476-482

Authors: Yeh, JSM Munn, SE Plunkett, TA Harper, PG Hopster, DJ du Vivier, AW

Citation: Jsm. Yeh et al., Coexistence of acanthosis nigricans and the sign of Leser-Trelat in a patient with gastric adenocarcinoma: A case report and literature review, J AM ACAD D, 42(2), 2000, pp. 357-362

Authors: Plunkett, TA Rubens, RD

Citation: Ta. Plunkett et Rd. Rubens, The biology and management of bone metastases, CR R ONC H, 31(1), 1999, pp. 89-96

Authors: Plunkett, TA Miles, DW

Citation: Ta. Plunkett et Dw. Miles, Immunotherapy: the last 25 years, CANC TR REV, 25(6), 1999, pp. 355-363

Authors: Houston, SJ Plunkett, TA Barnes, DM Smith, P Rubens, RD Miles, DW

Citation: Sj. Houston et al., Overexpression of c-erbB2 is an independent marker of resistance to endocrine therapy in advanced breast cancer, BR J CANC, 79(7-8), 1999, pp. 1220-1226